KWBT — Kiwa Bio-Tech Products Share Price
Last trade - 00:00- $0.06m
- $2.88m
- $40.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.01 | ||
| Price to Tang. Book | 0.01 | ||
| Price to Free Cashflow | 0.31 | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.08% | ||
| Return on Equity | -59.22% | ||
| Operating Margin | -2.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 9.62 | 17.27 | 30.65 | 40.09 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -31.75 | -69.01 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes and markets bio-technological products for agriculture. The Company operates primarily in the mainland China. The Company's products include biological organic fertilizer series, compound microbial fertilizer series, biological water-soluble fertilizer series, microorganism bacterium agent series and biological soil remediation series. Its biological organic fertilizer series include Bio-organic Fertilizer (50 million Bacteria/g), Bio-organic Fertilizer (200 million Bacteria/g) and Bio-organic Fertilizer (1 billion Bacteria/g). Its compound microbial fertilizer series include specialized fertilizers for fruit trees, tea trees, Chinese herbs, flowers, vegetables, tobacco and all crops. Its biological water-soluble fertilizer series includes Yimuling Water-soluble Biofertilizer. Its microorganism bacterium agent series include Microorganism Bacterium Agent, Difukang-Agricultural Microbial Inoculum and others.
Directors
- Last Annual
- December 31st, 2019
- Last Interim
- December 31st, 2019
- Incorporated
- July 21st, 2004
- Public Since
- May 26th, 1995
- No. of Shareholders
- 500
- No. of Employees
- 16
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 282,385,206
- Address
- 3200 Guasti Road,, Suite 100, ONTARIO, 91761
- Web
- https://www.kiwabiotech.com/
- Phone
- +1 6267155855
- Auditors
- Friedman LLP
Upcoming Events for KWBT
Similar to KWBT
Advanced Container Technologies
Pink Sheets on Nasdaq
Alkane
Pink Sheets on Nasdaq
American Battery Technology Co
Pink Sheets on Nasdaq
Angstrom Technologies
Pink Sheets on Nasdaq
Asia Carbon Industries
Pink Sheets on Nasdaq
FAQ
As of Today at 01:12 UTC, shares in Kiwa Bio-Tech Products are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Kiwa Bio-Tech Products last closed at $0.00 and the price had moved by -33.33% over the past 365 days. In terms of relative price strength the Kiwa Bio-Tech Products share price has underperformed the S&P500 Index by -41.64% over the past year.
There is no consensus recommendation for this security.
Kiwa Bio-Tech Products does not currently pay a dividend.
Kiwa Bio-Tech Products does not currently pay a dividend.
Kiwa Bio-Tech Products does not currently pay a dividend.
To buy shares in Kiwa Bio-Tech Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Kiwa Bio-Tech Products had a market capitalisation of $0.06m.
Here are the trading details for Kiwa Bio-Tech Products:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: KWBT
Based on an overall assessment of its quality, value and momentum Kiwa Bio-Tech Products is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kiwa Bio-Tech Products. Over the past six months, its share price has underperformed the S&P500 Index by -62.77%.
As of the last closing price of $0.00, shares in Kiwa Bio-Tech Products were trading -50.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kiwa Bio-Tech Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kiwa Bio-Tech Products' management team is headed by:
- Wade Li - CHM
- Hon Man Yun - CFO
- Xiao Qiang Yu - COO
- Qi Wang - VPR